Management of gestational diabetes mellitus
Annunziata Lapolla, Maria Grazia Dalfrà, Domenico FedeleDepartment of Medical and Surgical Sciences, Padova University, ItalyAbstract: The incidence of gestational diabetes mellitus (GDM) is on the increase and, if not diagnosed, managed and treated adequately, can have unfavorable ma...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-06-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
Online Access: | http://www.dovepress.com/management-of-gestational-diabetes-mellitus-a3266 |
id |
doaj-755d59defcb24749b5835bf51869dabe |
---|---|
record_format |
Article |
spelling |
doaj-755d59defcb24749b5835bf51869dabe2020-11-24T22:01:45ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy1178-70072009-06-012009default7382Management of gestational diabetes mellitusAnnunziata LapollaMaria Grazia DalfràDomenico FedeleAnnunziata Lapolla, Maria Grazia Dalfrà, Domenico FedeleDepartment of Medical and Surgical Sciences, Padova University, ItalyAbstract: The incidence of gestational diabetes mellitus (GDM) is on the increase and, if not diagnosed, managed and treated adequately, can have unfavorable maternal and fetal outcomes. Several studies have shown that glycemic values considered as adequate in the past when monitoring GDM failed to contain these adverse outcomes and randomized trials are needed to ascertain whether these targets should be lowered. Dietary restrictions remain the mainstay of GDM management and suitable physical exercise can help too. The use of rapid-acting insulin analogues (lispro and aspart) are novel treatments for improving metabolic control by reducing postprandial glycemia, while long-acting insulin analogues need to be evaluated by further studies for safety in clinical use before they can be prescribed. Numerous studies have found glyburide and metformin safe in women with GDM but more randomized controlled trials are needed, with a long-term follow-up of mother and child, to confirm these results.Keywords: gestational diabetes, glucose management, obstetric management, maternal complications, fetal complications http://www.dovepress.com/management-of-gestational-diabetes-mellitus-a3266 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Annunziata Lapolla Maria Grazia Dalfrà Domenico Fedele |
spellingShingle |
Annunziata Lapolla Maria Grazia Dalfrà Domenico Fedele Management of gestational diabetes mellitus Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
author_facet |
Annunziata Lapolla Maria Grazia Dalfrà Domenico Fedele |
author_sort |
Annunziata Lapolla |
title |
Management of gestational diabetes mellitus |
title_short |
Management of gestational diabetes mellitus |
title_full |
Management of gestational diabetes mellitus |
title_fullStr |
Management of gestational diabetes mellitus |
title_full_unstemmed |
Management of gestational diabetes mellitus |
title_sort |
management of gestational diabetes mellitus |
publisher |
Dove Medical Press |
series |
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
issn |
1178-7007 |
publishDate |
2009-06-01 |
description |
Annunziata Lapolla, Maria Grazia Dalfrà, Domenico FedeleDepartment of Medical and Surgical Sciences, Padova University, ItalyAbstract: The incidence of gestational diabetes mellitus (GDM) is on the increase and, if not diagnosed, managed and treated adequately, can have unfavorable maternal and fetal outcomes. Several studies have shown that glycemic values considered as adequate in the past when monitoring GDM failed to contain these adverse outcomes and randomized trials are needed to ascertain whether these targets should be lowered. Dietary restrictions remain the mainstay of GDM management and suitable physical exercise can help too. The use of rapid-acting insulin analogues (lispro and aspart) are novel treatments for improving metabolic control by reducing postprandial glycemia, while long-acting insulin analogues need to be evaluated by further studies for safety in clinical use before they can be prescribed. Numerous studies have found glyburide and metformin safe in women with GDM but more randomized controlled trials are needed, with a long-term follow-up of mother and child, to confirm these results.Keywords: gestational diabetes, glucose management, obstetric management, maternal complications, fetal complications |
url |
http://www.dovepress.com/management-of-gestational-diabetes-mellitus-a3266 |
work_keys_str_mv |
AT annunziatalapolla managementofgestationaldiabetesmellitus AT mariagraziadalframpagrave managementofgestationaldiabetesmellitus AT domenicofedele managementofgestationaldiabetesmellitus |
_version_ |
1725838720660144128 |